- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02531347
Comparison of Telemedical and Conventional Treatment of Hypertension
August 21, 2015 updated by: Erling Bjerregaard Pedersen
Treatment of Hypertension Using Telemedical Home Blood Pressure Measurements
The purpose of the study is to compare antihypertensive treatment based on either conventional blood pressure measurements or telemedical home blood pressure measurements.
Hypothesis is that telemedical treatment of hypertension is more effective in lowering blood pressure, is more cost-effective and provides better quality of life.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
375
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years to 64 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 55 to 64 years
- Registered address in the Municipality of Holstebro
- Enrolment at a practice of one of the general practitioners who had agreed to participate in the study
- Telemedical home blood pressure measurement with ≥12 measurements on day 2 and 3.
- Elevated home blood pressure ≥135/85 (if diagnosed diabetes, chronic kidney disease or prior stroke ≥130/80)
- Hypertension confirmed by daytime ambulatory blood pressure ≥135/85 (if diagnosed diabetes, chronic kidney disease or prior stroke ≥130/80)
- ECG verified sinus rhythm
Exclusion Criteria:
- Unwillingness to participate
- Normotension
- Withdrawal of consent to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Telemedical blood pressure monitoring
Telemedical home blood pressure measurements for three days every second week.
The average of all measures excluding day one is electronically transmitted to the General Practitioners.
Following communication primarily by email or telephone.
|
|
|
Active Comparator: Conventional blood pressure monitoring
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood pressure reduction
Time Frame: 3 month
|
Difference in daytime ambulatory blood pressure from baseline to followup between intervention and control group
|
3 month
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of patients reaching target blood pressure
Time Frame: 3 month
|
3 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nikolai Hoffmann-Petersen, MD, Department of Medical Research and Medicine, Holstebro Regional Hospital, Holstebro, Denmark
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
August 20, 2015
First Submitted That Met QC Criteria
August 21, 2015
First Posted (Estimate)
August 24, 2015
Study Record Updates
Last Update Posted (Estimate)
August 24, 2015
Last Update Submitted That Met QC Criteria
August 21, 2015
Last Verified
August 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- M-20110013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on Telemedical home blood pressure measurements
-
Erling Bjerregaard PedersenCompleted
-
Regional Hospital HolstebroCompleted
-
Oslo University HospitalTerminatedCardiovascular Diseases | Hypertension | Kidney Transplant; ComplicationsNorway
-
North-West University, South AfricaUniversity of Zurich; University of Cape Town; Medical Research Council, South... and other collaboratorsRecruitingHypertension | Obesity, Childhood | Obesity, AdolescentSouth Africa, Switzerland
-
Boehringer IngelheimCompleted
-
Aktiia SARecruitingHypertension | Cardiovascular Risk | Blood Pressure Check (Hypertension Screening)Switzerland, United Kingdom
-
Boryung Pharmaceutical Co., LtdCompletedHypertensionKorea, Republic of
-
Meir Medical CenterNovartis PharmaceuticalsTerminatedBlood Pressure, HighIsrael
-
Hasselt UniversityJessa HospitalCompleted
-
University of Maryland, BaltimoreTerminated